Ambient Assisted Living Joint Programme (AAL JP): Catalogue of Projects 2014

Ambient Assisted Living Joint Programme (AAL JP) is financed by the European Commission and the 22 countries that constitute the partner states of this joint initiative: Austria, Belgium, Cyprus, Denmark, Finland, France, Germany, Hungary, Ireland, Israel, Italy, Luxembourg, the Netherlands, Norway, Poland, Portugal, Romania, Slovenia, Spain, Sweden, Switzerland and the United Kingdom. The initial phase of the AAL JP was set up for a duration of 6 years, from 2008 to 2013. The programme's planned total budget was 600 M€, of which approx. 50% was public funding - from the AAL partner states and the European Commission - and approx. 50% was private funding from participating organisations.

The objective of the AAL JP is to enhance the quality of life of older adults and strengthen the industrial base in Europe through the use of information and communication technologies (ICT). The most important activity of the AAL Joint Programme is the funding of research, development and innovation projects in the field of ICT for active and healthy ageing within the user-driven-innovation and close to market paradigms. It also finances other activities supporting the programme and it organizes the annual Forum to showcase all solutions to the European audience.

Download: Ambient Assisted Living Joint Programme (AAL JP): Catalogue of Projects 2014 (.pdf, 13.570 KB).

Download from eHealthNews.eu: Ambient Assisted Living Joint Programme (AAL JP): Catalogue of Projects 2014 (.pdf, 13.570 KB).

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...